天天av福利整合五月天激情综合网视频播放资源，支持9i制作厂网页版入口手机在线点播，国产麻豆精品一区二区

Chitra Lal
No Rating Available
(Learn About Our Rating System)

Chitra Lal, ATSF, FAASM, FACP, FCCP, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Medical Intensive Care Unit
Salt Lake City
801-581-2121

Sleep Wake Center

Sleep Wake Services
Salt Lake City
801-581-7806

University of Utah Hospital

Medical Intensive Care Unit
Salt Lake City
801-581-2121

University of Utah Hospital

Pulmonary, Clinic 3
Salt Lake City
801-581-7806

  • Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)
    American Board of Internal Medicine (Sub: Sleep Medicine)
    American Board of Sleep Medicine

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Professor (Clinical)
    Academic Divisions Public Health
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)
    American Board of Internal Medicine (Sub: Sleep Medicine)
    American Board of Sleep Medicine

    Education history

    Fellowship Pulmonary/Critical Care/Sleep Medicine - University of Tennessee Health Science Center Fellow
    Residency Internal Medicine - St. Joseph Hospital Resident
    Residency Pediatrics, Diploma in Child Health - Maulana Azad Medical College (MAMC), University of Delhi Resident
    Undergraduate Medicine, Surgery - Maulana Azad Medical College (MAMC), University of Delhi M.B.B.S.

    Selected Publications

    Journal Article

    1. Marrero-Gonzalez AR, Salvador CD, Nguyen SA, Meyer TA, Ford DW, Rinn AM, Lal C, Swanson M, Abdelwahab M (2024). Depressive symptoms after surgical and medical management of OSA: a systematic review and meta-analysis. Sleep Breath, 29(1), 64. (Read full article)
    2. Lal C (2024). Obstructive Sleep Apnea and Sarcoidosis Interactions [Review]. Sleep Med Clin, 19(2), 295-305. (Read full article)
    3. Steier JS, Bogan RK, Cano-Pumarega IM, Fleetham JA, Insalaco G, Lal C, Ppin JL, Randerath WJ, Redline S, Malhotra A (2023). Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea - A Delphi consensus study [Review]. Sleep Med, 112, 104-115. (Read full article)
    4. Lal C, Ayappa I, Ayas N, Beaudin AE, Hoyos C, Kushida CA, Kaminska M, Mullins A, Naismith SL, Osorio RS, Phillips CL, Parekh A, Stone KL, Turner AD, Varga AW (2022). The Link between Obstructive Sleep Apnea and Neurocognitive Impairment: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc, 19(8), 1245-1256. (Read full article)
    5. Khan A, Clay RD, Singh A, Lal C, Tereshchenko LG (2022). Ventricular Arrhythmias in Patients with Implanted Cardiac Devices at High Risk of Obstructive Sleep Apnea. Medicina (Kaunas), 58(6). (Read full article)
    6. Lal C, Weaver TE, Bae CJ, Strohl KP (2021). Excessive Daytime Sleepiness in Obstructive Sleep Apnea. Mechanisms and Clinical Management [Review]. Ann Am Thorac Soc, 18(5), 757-768. (Read full article)
    7. Strange C, Richard CL, Shan S, Phillips BA, Kanotra S, Drummond MB, Megenhardt L, Lal C, Pleasants RA (2020). A population-based estimate of the health care burden of obstructive sleep apnea using a STOP-BAG questionnaire in South Carolina. J Clin Sleep Med, 17(3), 367-374. (Read full article)
    8. Lal C, Kumbhare S, Strange C (2019). Prevalence of self-reported sleep problems amongst adults with obstructive airway disease in the NHANES cohort in the United States. Sleep Breath, 24(3), 985-993. (Read full article)
    9. Lal C, Khan A (2019). Emerging Treatments for COPD: Evidence to Date on Revefenacin [Review]. COPD, 17(1), 112-119. (Read full article)
    10. Lal C, Strange C (2019). Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD). Expert Opin Pharmacother, 20(9), 1075-1085. (Read full article)
    11. Lal C, Hardiman G, Kumbhare S, Strange C (2018). Proteomic biomarkers of cognitive impairment in obstructive sleep apnea syndrome. Sleep Breath, 23(1), 251-257. (Read full article)
    12. Ong AA, Atwood CM, Nguyen SA, Teufel RJ 2nd, Lal C, LaRosa AC, White DR (2017). Down syndrome and pediatric obstructive sleep apnea surgery: A national cohort. Laryngoscope, 128(8), 1963-1969. (Read full article)
    13. Lal C, Strange C (2017). A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD [Review]. Expert Opin Pharmacother, 18(17), 1833-1843. (Read full article)
    14. DEsposito CF, Farhood Z, Baker AB, Nguyen SA, LaRosa AC, Lal C, White DR (2017). Assessment of weight gain following adenotonsillectomy in children with Down syndrome. Int J Pediatr Otorhinolaryngol, 100, 103-106. (Read full article)
    15. Abuzaid AS, Al Ashry HS, Elbadawi A, Ld H, Saad M, Elgendy IY, Elgendy A, Mahmoud AN, Mentias A, Barakat A, Lal C (2017). Meta-Analysis of Cardiovascular Outcomes With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea [Review]. Am J Cardiol, 120(4), 693-699. (Read full article)
    16. Lal C, Strange C (2016). Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy [Review]. Int J Chron Obstruct Pulmon Dis, 12, 135-140. (Read full article)
    17. Lal C, DiBartolo MM, Kumbhare S, Strange C, Joseph JE (2015). Impact of obstructive sleep apnea syndrome on cognition in early postmenopausal women. Sleep Breath, 20(2), 621-6. (Read full article)
    18. Balachandran JS, Thomson CC, Sumter DB, Shelgikar AV, Lachapelle P, Pamidi S, Fall M, Lal C, Baba RY, Shah N, Fields BG, Sarmiento K, Butler MP, Shea SA, Baptiste JV, Sharkey KM, Wang T (2016). ATS Core Curriculum 2016: Part I. Adult Sleep Medicine. Ann Am Thorac Soc, 13(4), 549-61. (Read full article)
    19. Lal C, Medarov BI, Judson MA (2015). Interrelationship between sleep-disordered breathing and sarcoidosis [Review]. Chest, 148(4), 1105-1114. (Read full article)
    20. Zhu X, Kelly TH, Curry TE Jr, Lal C, Joseph JE (2015). Altered functional brain asymmetry for mental rotation: effect of estradiol changes across the menstrual cycle. Neuroreport, 26(14), 814-9. (Read full article)
    21. Lal C, Siddiqi N, Kumbhare S, Strange C (2015). Impact of medications on cognitive function in obstructive sleep apnea syndrome. Sleep Breath, 19(3), 939-45. (Read full article)
    22. Lal C, White DR, Joseph JE, van Bakergem K, LaRosa A (2015). Sleep-disordered breathing in Down syndrome [Review]. Chest, 147(2), 570-579. (Read full article)
    23. Bade BC, Strange C, Lal C (2014). Effect of obstructive sleep apnea treatment on mail-in cognitive function screening instrument. Am J Med Sci, 348(3), 215-8. (Read full article)
    24. Lal C, Huggins JT, Sahn SA (2012). Parasitic diseases of the pleura [Review]. Am J Med Sci, 345(5), 385-9. (Read full article)
    25. Lal C, Strange C, Bachman D (2012). Neurocognitive impairment in obstructive sleep apnea [Review]. Chest, 141(6), 1601-1610. (Read full article)
    26. Lal C, Barker J, Strange C (2011). Unilateral pulmonary artery aplasia in a pregnant patient. Case Rep Med, 2011, 806723. (Read full article)

    Case Report

    1. McLeroy LD, Daly DD, Rier JD, Lal C, Fernandes VL (2017). Pulmonary Embolism in Transit Before Pulseless Electrical Activity Arrest. Am J Med Sci, 354(4), 436-437. (Read full article)

    Editorial

    1. Lal C (2017). Sleep-disordered Breathing and Cognitive Impairment: A Subtle but Important Association. Ann Am Thorac Soc, 14(11), 1636-1637. (Read full article)

    Letter

    1. Lal C, Weiman D, Eltorky M, Pugazhenthi M (2005). Complete resolution of fibrosing mediastinitis with corticosteroid therapy. [Letter to the editor]. South Med J, 98(7), 749-50. (Read full article)

    Other

    1. Strollo PJ Jr, Hedner J, Collop N, Lorch DG Jr, Chen D, Carter LP, Lu Y, Lee L, Black J, Ppin JL, Redline S, Tones 4 Study Investigators (2018). Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study. Chest (155(2), pp. 364-374). United States. (Read full article)